TSE:CPH Cipher Pharmaceuticals (CPH) Stock Price, News & Analysis C$13.57 +0.23 (+1.72%) As of 07/4/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Cipher Pharmaceuticals Stock (TSE:CPH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cipher Pharmaceuticals alerts:Sign Up Key Stats Today's RangeC$13.38▼C$13.6650-Day RangeC$12.10▼C$14.5652-Week RangeC$8.18▼C$19.69Volume6,853 shsAverage Volume30,127 shsMarket CapitalizationC$243.63 millionP/E Ratio14.99Dividend YieldN/APrice TargetC$14.75Consensus RatingModerate Buy Company Overview Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States. Read More Cipher Pharmaceuticals Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreCPH MarketRank™: Cipher Pharmaceuticals scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingModerate Buy Consensus RatingCipher Pharmaceuticals has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCipher Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.Read more about Cipher Pharmaceuticals' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cipher Pharmaceuticals is 14.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.65.Price to Earnings Ratio vs. SectorThe P/E ratio of Cipher Pharmaceuticals is 14.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.66.Price to Book Value per Share RatioCipher Pharmaceuticals has a P/B Ratio of 3.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CPH. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCipher Pharmaceuticals does not currently pay a dividend.Dividend GrowthCipher Pharmaceuticals does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for CPH. News and Social Media2.0 / 5News SentimentN/A News SentimentCipher Pharmaceuticals has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cipher Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by Insiders42.00% of the stock of Cipher Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 1.38% of the stock of Cipher Pharmaceuticals is held by institutions.Read more about Cipher Pharmaceuticals' insider trading history. Receive CPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CPH Stock News HeadlinesCPH - Cipher Pharmaceuticals Inc Key Metrics - MorningstarJune 24, 2025 | morningstar.comMEarnings call transcript: Cipher Pharmaceuticals misses Q1 2025 EPS expectationsMay 11, 2025 | uk.investing.comHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.July 5 at 2:00 AM | Timothy Sykes (Ad)Earnings call transcript: Cipher Pharmaceuticals Q4 2024 sees stock surgeMarch 21, 2025 | uk.investing.comCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 ResultsMarch 19, 2025 | theglobeandmail.comCipher Pharmaceuticals Inc.'s (TSE:CPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?March 17, 2025 | uk.finance.yahoo.comCipher Pharmaceuticals Inc. (TSE:CPH) most popular amongst individual investors who own 57%, insiders hold 42%February 4, 2025 | finance.yahoo.comThis Healthcare Stock Could Be the Best Investment of the DecadeJanuary 31, 2025 | msn.comSee More Headlines CPH Stock Analysis - Frequently Asked Questions How have CPH shares performed this year? Cipher Pharmaceuticals' stock was trading at C$14.32 on January 1st, 2025. Since then, CPH shares have decreased by 5.2% and is now trading at C$13.57. How were Cipher Pharmaceuticals' earnings last quarter? Cipher Pharmaceuticals Inc. (TSE:CPH) released its quarterly earnings data on Thursday, August, 10th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.15 by $0.01. The company had revenue of $7.10 million for the quarter, compared to analyst estimates of $7.46 million. Cipher Pharmaceuticals had a trailing twelve-month return on equity of 17.93% and a net margin of 59.92%. Read the conference call transcript. How do I buy shares of Cipher Pharmaceuticals? Shares of CPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Cipher Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cipher Pharmaceuticals investors own include Cipher Pharmaceuticals (CPHRF), Enbridge (ENB), Bellatrix Exploration (BXE), Crescent Point Energy (CPG), Manulife Financial (MFC), Surge Energy (SGY) and Toronto-Dominion Bank (TD). Company Calendar Last Earnings8/10/2023Today7/05/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:CPH Previous SymbolTSE:DND CIKN/A Webwww.cipherpharma.com Phone+1-905-6025840FaxN/AEmployees5Year FoundedN/APrice Target and Rating Average Stock Price TargetC$14.75 High Stock Price TargetC$17.00 Low Stock Price TargetC$12.50 Potential Upside/Downside+8.7%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)C$0.91 Trailing P/E Ratio14.99 Forward P/E Ratio10.51 P/E GrowthN/ANet IncomeC$11.41 million Net Margins59.92% Pretax MarginN/A Return on Equity17.93% Return on Assets7.90% Debt Debt-to-Equity Ratio41.22 Current Ratio2.00 Quick Ratio2.67 Sales & Book Value Annual SalesC$19.03 million Price / Sales12.80 Cash FlowC$3.85 per share Price / Cash Flow3.53 Book ValueC$3.96 per share Price / Book3.43Miscellaneous Outstanding Shares17,953,309Free FloatN/AMarket CapC$243.63 million OptionableNot Optionable Beta1.20 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (TSE:CPH) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cipher Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.